Rising number of coronavirus infections in some regions could lead to fourth surge of illness in U.S.
The Biden administration reached a major milestone on Friday, with 100 million U.S. residents receiving at least one dose of the COVID-19 vaccine by April 2.
The United States became the first country in the world to achieve this vaccination success. However, COVID-19 cases continue to grow in some regions of the United States.
Earlier this week, President Joe Biden said that as the vaccination rate increases, at least 90 percent of American adults will be eligible for the vaccine by April 19. Previously, Biden had promised to reach that figure by May 1.
But during a briefing by the Coronavirus Task Force at the White House earlier this week, the head of the U.S. Centers for Disease Control and Prevention (CDC), Dr. Rochelle Walenski, warned of the danger of too many Americans over complying with COVID-19 restrictions.
President Biden suggested that if this trend continues, there could be a fourth spike in COVID-19 infections in the U.S.
Compared to the U.S., European countries are lagging behind in vaccination programs. The World Health Organization reported that only 10% of Europe’s population received one dose of vaccine, and only 4% received two doses.
One reason for the lag is the European Union’s dependence on the AstraZeneca vaccine, which has been plagued by trouble – in particular, many countries have reported complications from the vaccine related to blood clotting. The Netherlands on Friday followed Germany, which stopped using the vaccine for people under 60.
Cases of blood clots due to this vaccine are extremely rare. The European Medicines Agency said the AstraZeneca vaccine is safe.
“We have to be cautious, so it would be wise to hit the pause button now as a precautionary measure,” said Dutch Health Minister Hugo de Jonge.